1. Home
  2. BRC vs LGND Comparison

BRC vs LGND Comparison

Compare BRC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

HOLD

Current Price

$83.31

Market Cap

4.1B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$202.24

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRC
LGND
Founded
1914
1987
Country
United States
United States
Employees
N/A
68
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
BRC
LGND
Price
$83.31
$202.24
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$1.20
$245.86
AVG Volume (30 Days)
170.4K
193.0K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
1.17%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,144,698,000.00
N/A
Revenue This Year
$7.36
$1.61
Revenue Next Year
$3.57
$18.93
P/E Ratio
$23.35
$76.27
Revenue Growth
5.86
N/A
52 Week Low
$65.76
$98.90
52 Week High
$99.29
$227.92

Technical Indicators

Market Signals
Indicator
BRC
LGND
Relative Strength Index (RSI) 47.61 49.86
Support Level $76.10 $197.34
Resistance Level $86.37 $207.72
Average True Range (ATR) 2.21 7.84
MACD 0.40 -0.02
Stochastic Oscillator 73.80 52.97

Price Performance

Historical Comparison
BRC
LGND

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: